- Home
- EU vs CYRX Comparison
EU vs CYRX Comparison
Compare EU & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EU
- CYRX
- Stock Information
- Founded
- EU 2009
- CYRX 1999
- Country
- EU United States
- CYRX United States
- Employees
- EU N/A
- CYRX N/A
- Industry
- EU Other Metals and Minerals
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- EU Basic Materials
- CYRX Health Care
- Exchange
- EU Nasdaq
- CYRX Nasdaq
- Market Cap
- EU 494.0M
- CYRX 438.7M
- IPO Year
- EU N/A
- CYRX N/A
- Fundamental
- Price
- EU $2.69
- CYRX $8.84
- Analyst Decision
- EU Strong Buy
- CYRX Strong Buy
- Analyst Count
- EU 1
- CYRX 9
- Target Price
- EU $4.00
- CYRX $12.83
- AVG Volume (30 Days)
- EU 4.1M
- CYRX 909.8K
- Earning Date
- EU 11-10-2025
- CYRX 11-04-2025
- Dividend Yield
- EU N/A
- CYRX N/A
- EPS Growth
- EU N/A
- CYRX N/A
- EPS
- EU N/A
- CYRX 1.27
- Revenue
- EU $44,142,000.00
- CYRX $243,795,000.00
- Revenue This Year
- EU $26.12
- CYRX N/A
- Revenue Next Year
- EU $103.15
- CYRX $9.20
- P/E Ratio
- EU N/A
- CYRX $6.94
- Revenue Growth
- EU N/A
- CYRX 41.27
- 52 Week Low
- EU $1.01
- CYRX $4.58
- 52 Week High
- EU $4.19
- CYRX $11.44
- Technical
- Relative Strength Index (RSI)
- EU 42.17
- CYRX 45.11
- Support Level
- EU $2.55
- CYRX $8.14
- Resistance Level
- EU $2.82
- CYRX $9.29
- Average True Range (ATR)
- EU 0.19
- CYRX 0.64
- MACD
- EU -0.05
- CYRX -0.09
- Stochastic Oscillator
- EU 26.27
- CYRX 23.29
About EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.